FDA approves Ryzumvi eye drops for presbyopia
The FDA has approved Ryzumvi (phentolamine 0.75%) eye drops to treat presbyopia in adults, marking a label expansion for the product marketed by Viatris.
3 sourcesFDA drug approval
00
The FDA has approved Ryzumvi (phentolamine 0.75%) eye drops to treat presbyopia in adults, marking a label expansion for the product marketed by Viatris.